(ALNY) - Analyzing Alnylam Pharmaceuticals's Short Interest

Alnylam Pharmaceuticals's (NYSE:ALNY) short percent of float has risen 4.82% since its last report. The company recently reported that it has 2.63 million shares sold short, which is 2.39% of all regu

BenzingaMay 17 14:30

S&P 500 Futures Rise In Premarket Trading; GameStop, Deere Lag

This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, Chubb Ltd. (CB) was up 8.0% in pre-market trading,

Dow JonesMay 16 06:31

Most Attractive Short-term Overwriting Stocks for June Expiration - Goldman

Goldman Sachs analysts identified short-term overwriting opportunities in large-cap, high implied volatility stocks that do not have earnings events.

Seeking AlphaMay 15 09:43

S&P 500 Futures Steady In Premarket Trading; Monday.Com, Nextracker Lead

This article was automatically generated by Barrons.com using technology from Automated Insights. With U.S. stock markets set to open in two hours, monday.com Ltd. (MNDY) was up 19.4% in pre-market t

Dow JonesMay 15 06:31

10 Health Care Stocks With Whale Alerts In Today's Session

Traders will search for circumstances when the market estimation of an option diverges heavily from its normal worth.

BenzingaMay 9 12:35

HC Wainwright Adjusts Price Target on Alnylam Pharmaceuticals to $400 From $395, Maintains Buy Rating

Alnylam Pharmaceuticals (ALNY) has an average outperform rating and a price target range of $138 to $400, according to analysts polled by Capital IQ.

MT NewswiresMay 7 08:12